Mcerts Approved Cems

首页> 外文期刊>International Environmental Technology >Mcerts Approved Cems

【24h】

Mcerts Approved Cems

机译：Mcerts批准的Cems

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

The Gasmet AMS (CEMS) uses an FTIR analyser, the established technique for multi-component gas emissions measurements. A single Gasmet Cx-4000 analyser can perform analysis of a complex gas mixture in a hot, wet gas stream with the highest preciston. MCERTS approved, the AMS incorporates the analysers and sample handling components as well as a PC to run the analyser and provide data output.

机译：Gasmet AMS（CEMS）使用FTIR分析仪，该分析仪是用于多组分气体排放测量的成熟技术。一台Gasmet Cx-4000分析仪可以对具有高精确度的湿热气流中的复杂气体混合物进行分析。 AMS集成了分析仪和样品处理组件以及经过分析仪和样品处理组件的PC以及运行分析仪并提供数据输出的PC。

著录项

来源
《International Environmental Technology》 |2011年第1期|p.ⅶ|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. MCERTS Approved CEMS [J] . International environmental technology . 2012,第2期

机译：MCERTS批准的CEMS
2. MCERTS Approved CEMS [J] . International environmental technology . 2012,第1期

机译：MCERTS批准的CEMS
3. MCERTS Approved CEMS [J] . International environmental technology . 2011,第2期

机译：MCERTS批准的CEMS
4. Dose enhancement during concomitant chemoradiotherapy using FDA approved concentrations of carboplatin and oxaliplatin nanoparticles [C] . Gizem Cifter, Yucel Altundal, Alex Detappe World Congress on Medical Physics and Biomedical Engineering . 2015

机译：使用FDA批准的Carboplatin和Oxaliplatin纳米粒子伴随的伴随化学疗法期间的剂量增强
5. ALDH2 Deficiency: Lack of Approved Treatments Efficient at Decreasing Serum Acetaldehyde Levels [D] . Chen, Michelle. 2021

机译：Aldh2缺乏：缺乏经批准的治疗效率降低血清乙醛水平
6. Summaries of Safety Labeling Changes Approved By FDA- Boxed Warnings Highlights October-December 2017 [O] . 2018

机译：FDA批准的安全标签变更摘要-盒装警告摘要2017年10月至12月
7. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines) 11This document was approved by the American College of Cardiology Foundation Board of Trustees in September 2002, the American Heart Association Science Advisory and Coordinating Committee in August 2002, and the North American Society for Pacing and Electrophysiology in August 2002.22The ACC/AHA Task Force on Practice Guidelines makes every effort to avoid any actual or potential conflicts of interest that might arise as a result of an outside relationship or personal interest of a member of the writing panel. Specifically, all members of the writing panel are asked to provide disclosure statements of all such relationships that might be perceived as real or potential conflicts of interest. These statements are reviewed by the parent task force, reported orally to all members of the writing panel at the first meeting, and updated as changes occur. The conflict of interest information for the writing committee members is posted on the ACC, AHA, and NASPE Web sites with the full-length version of the update.33When citing this document, the ACC, the AHA, and NASPE would appreciate the following citation format: Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol2002;40:1703–19.44Copies: This document is available on the World Wide Web sites of the ACC (www.acc.org) and the AHA (www.americanheart.org). A single copy of the complete guidelines is available by calling 800-253-4636 (US only) or writing the American College of Cardiology, Resource Center, 9111 Old Georgetown Road, Bethesda, MD 20814-1699 (ask for No. 71-0237). To obtain a copy of the Summary Article, ask for reprint No. 71-0236. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail kbradle@lww.com.55(J Am Coll Cardiol 2002;40:1703–19.)66©2002 by the American College of Cardiology Foundation and the American Heart Association, Inc. [O] . Gregoratos Gabriel, Abrams Jonathan, Epstein Andrew E, 2002

机译：ACC / AHA / NASPE 2002心脏起搏器和抗心律失常装置植入指南更新-总结文章美国心脏病学会/美国心脏协会实践指南工作组的报告（ACC / AHA / NASPE委员会将更新1998年起搏器指南） 11该文件于2002年9月获得美国心脏病学会基金会董事会的批准，于2002年8月获得美国心脏协会科学咨询和协调委员会的批准，并于2002年8月获得北美起搏和电生理学会的批准。22ACC / AHA工作组《实践指南》将尽一切努力避免由于写作小组成员的外部关系或个人利益而引起的任何实际或潜在的利益冲突。具体来说，要求写作小组的所有成员提供所有可能被视为实际或潜在利益冲突的关系的披露声明。这些声明由上级工作组审核，在第一次会议上口头报告给写作小组的所有成员，并在发生变化时进行更新。撰写委员会成员的利益冲突信息已发布在更新的完整版本的ACC，AHA和NASPE网站上。33当引用本文档时，ACC，AHA和NASPE将不胜感激。格式：Gregoratos G，Abrams J，Epstein AE，Freedman RA，Hayes DL，Hlatky MA，Kerber RE，Naccarelli GV，Schoenfeld MH，Silka MJ，Winters SL。 ACC / AHA / NASPE 2002心脏起搏器和抗心律失常装置植入指南更新-总结文章：美国心脏病学会/美国心脏协会实践指南工作组的报告（ACC / AHA / NASPE委员会更新了1998年起搏器指南）。 J Am Coll Cardiol2002； 40：1703–19.44复制：此文档可在ACC（www.acc.org）和AHA（www.americanheart.org）的万维网站点上找到。您可以致电800-253-4636（仅限美国）或写信给美国心脏病学会资源中心，地址为9111 Old Georgetown Road，Bethesda，MD 20814-1699，获得一份完整的指南（请致电71-0237））。要获得摘要文章的副本，请索要第71-0236号转载。要购买其他重印本（指定版本和重印本号码）：最多999份，请致电800-611-6083（仅限美国）或传真413-665-2671；否则，请重新发送。 1000份或更多，请致电410-528-4426，传真410-528-4264或发送电子邮件至kbradle@lww.com.55（J Am Coll Cardiol 2002； 40：1703–19。）66©2002美国心脏病学基金会基金会和美国心脏协会有限公司

Mcerts Approved Cems

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅